Zevra Therapeutics $ZVRA Eyes FDA Approval for Arimoclomol: A High-Stakes...
Zevra Therapeutics has transformed from a speculative entity to a focused player in rare disease treatment, with the spotlight on Arimoclomol, targeting Niemann-Pick disease. Anticipation mounts for the FDA's decision...